Melatonine Linn

Melatonin, the active ingredient in Melatonine Linn, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to support sleep onset and regulate circadian rhythm in adults experiencing insomnia or jet‑lag related disturbances.

GNH USA supplies Melatonine Linn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonine Linn acts on melatonin receptors to address sleep‑related disorders.

Insomnia: helps reduce time to fall asleep and improve sleep quality. Jet lag: assists in adjusting the internal clock after rapid time‑zone travel. Circadian rhythm disturbances: supports alignment of the sleep‑wake cycle in shift‑work or delayed‑sleep‑phase conditions.

Melatonine Linn may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate discomfort. - Dizziness: sensation of light‑headedness. - Daytime sleepiness: feeling unusually tired during waking hours. - Nausea: mild stomach upset. - Mild gastrointestinal discomfort: occasional stomach cramps.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Mood changes: depression or increased anxiety. - Severe dizziness or vertigo. - Hallucinations or vivid dreams. - Significant cardiovascular effects: rapid heartbeat or chest pain.

When considering Melatonine Linn, several safety measures should be observed.

Assess sleep patterns: evaluate the underlying cause of sleep difficulty before use. Avoid operating machinery: do not drive or use heavy equipment if drowsiness occurs. Monitor mood: be alert for signs of depression or anxiety. Use with caution in children: only under medical supervision. Consider anticoagulant therapy: discuss with a healthcare professional. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Melatonine Linn can interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Immunosuppressants (e.g., cyclosporine): altered drug levels. - Central nervous system depressants (e.g., benzodiazepines): enhanced sedation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in efficacy. - Antidepressants (e.g., SSRIs): potential serotonin‑related effects. - Antihypertensives: may influence blood pressure control.